captured official filings
Inhibitor Therapeutics, Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filing
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
Public registration text delta
Comparing S-1/A filed 2016-07-18 with S-1/A filed 2016-07-21.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- management17 → 0-17
- shares48 → 39-9
- proceeds8 → 1-7
- risk factor7 → 0-7
- going concern5 → 0-5
- offering20 → 24+4
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
- EXPLANATORY NOTE This Amendment No. 2 to the Registration Statement is being filed to update the Calculation of Registration Fee Table to reflect the reduction in the number of shares registered under this Registration Statement and to attach a revised Exhibit 5.2.
- RECENT SALES OF UNREGISTERED SECURITIES On August 13, 2013, we issued to Hedgepath, LLC, as consideration for the contribution of certain assets as described in that certain contribution agreement, dated August 13, 2013 by and between us and Hedgepath, LLC, an aggregate of 170,000.739 shares of Series A Preferred Stock which hav
- Pursuant to such agreement, Hedgepath, LLC purchased 20,000,000 shares of our common stock at a purchase price of $0.075 per share for an aggregate purchase price of $1,500,000.
- This registration does not mean that the selling stockholders named herein will actually offer or sell any of these shares.
- We will not receive any proceeds from the resale of the above shares of our common stock by the selling shareholders.
- However, we may receive proceeds from the exercise of the warrants exercised other than pursuant to any applicable cashless exercise provisions of the warrants.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
Captured filing chronology
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 5OwnershipOpen SEC filing →
- 5OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- SC 13DOwnershipOpen SEC filing →
- SC 13GOwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- SC 13GOwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.